Gliknik News Releases

2/25/2013 Gliknik adds Incyte President & Ceo Paul A. Friedman
to its Board if Directors Read More

12/20/2012 Gliknik Announces Interim Clinical Data From Use of Its Immunomodulator Drug Candidate in Multiple Myeloma Patients Read More

10/8/2012 Gliknik Raises $4.9 Million in Series B Financing Led by Baxter Ventures Read More

9/12/2012 Published Preclinical Data Demonstrate Ability of Gliknik’s Recombinant Stradomers^TM to Mimic Anti-Autoimmune Effect of IVIG Read More

10/3/2011 National Cancer Institute Awards Gliknik Up to $1.5 Million in SBIR Funding Read More